tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SPRO Stock Latest News

Spero Therapeutics Details Pipeline Progress and Future Goals
Company AnnouncementsSpero Therapeutics Details Pipeline Progress and Future Goals
7d ago
8K
SPRO
Spero Therapeutics upgraded to Buy from Hold at TD Cowen
PremiumThe Fly
Spero Therapeutics upgraded to Buy from Hold at TD Cowen
1M ago
SPRO
Spero Therapeutics Updates Investors with New Presentation
PremiumCompany Announcements
Spero Therapeutics Updates Investors with New Presentation
1M ago
8K
SPRO
Spero announces Kamal Hamed, MD, CMO departing effective August 29
PremiumThe Fly
Spero announces Kamal Hamed, MD, CMO departing effective August 29
1M ago
GSK
SPRO
Spero Therapeutics reports Q 2 EPS (33c), consensus (38c)
PremiumThe Fly
Spero Therapeutics reports Q 2 EPS (33c), consensus (38c)
1M ago
SPRO
Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update
PremiumPress ReleasesSpero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update
1M ago
SPRO
SPRO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SPRO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
SPRO
Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024
Premium
Press Releases
Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024
2M ago
SPRO
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3M ago
SPRO
Spero Therapeutics Expands Stock Incentive Plan for Growth
PremiumCompany Announcements
Spero Therapeutics Expands Stock Incentive Plan for Growth
4M ago
8K
SPRO
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4M ago
SPRO
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
PremiumPress Releases
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
4M ago
SPRO
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
PremiumPress ReleasesSpero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
4M ago
SPRO
Spero Therapeutics reports Q1 EPS (24c), consensus (4c)
Premium
The Fly
Spero Therapeutics reports Q1 EPS (24c), consensus (4c)
4M ago
SPRO
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
Premium
Press Releases
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
4M ago
SPRO
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5M ago
SPRO
Spero Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Spero Therapeutics files $300M mixed securities shelf
6M ago
SPRO
Spero Therapeutics reports Q4 EPS (96c), consensus (10c)
PremiumThe Fly
Spero Therapeutics reports Q4 EPS (96c), consensus (10c)
6M ago
SPRO
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
PremiumPress Releases
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
6M ago
SPRO
Is SPRO a Buy, Before Earnings?
PremiumPre-EarningsIs SPRO a Buy, Before Earnings?
6M ago
SPRO
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
Premium
Press Releases
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
7M ago
SPRO
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
7M ago
ANTX
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >